Aspera Biomedicines is a space-accelerated biotechnology company pioneering therapies that target cancer stem cells.
Aspera Biomedicines has raised $3.2M in total funding. The most recent round was Grant. The last funding was announced in May 2025.
Aspera Biomedicines's investors include California Institute for Regenerative Medicine.
Aspera Biomedicines is headquartered in La Jolla, United States.
Aspera Biomedicines is a space-accelerated biotechnology company pioneering therapies that target cancer stem cells.
Aspera Biomedicines is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aspera Biomedicines — Funding & Investors." VCBacked, May 29, 2025, https://www.vcbacked.co/company/aspera-biomedicines. Accessed August 14, 2026.
VCBacked. (2025). Aspera Biomedicines — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/aspera-biomedicines
{{cite web |title=Aspera Biomedicines — Funding & Investors |url=https://www.vcbacked.co/company/aspera-biomedicines |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated